Doximity to Provide New Clinical AI Tools Across NewYork-Presbyterian, Columbia University and Weill Cornell Medicine
More Than Half of U.S. Physicians Now Use AI In Their Practice Daily, But Few Have Clear Rules For It
Doximity CEO Jeff Tangney on Putting Doctors First as AI Rewrites Healthcare
Barclays Maintains Equal-Weight on Doximity, Raises Price Target to $30
Doximity (DOCS) Rolls Out DoseCheck After Near Zero Drug Dosing Errors
Freedom Capital Markets Maintains Hold on Doximity, Raises Price Target to $32
Doximity: 3 Key Takeaways for Long-Term Investors
DOCS Q3 CY2026 deep dive: AI-driven product expansion meets margin compression
Doximity Q2 Earnings Call Highlights
Doximity earnings analysis: questions answered and next catalysts
Doximity, Inc. (DOCS) Q2 2027 Earnings Call Transcript
Canaccord Genuity Maintains Buy on Doximity, Raises Price Target to $40
RBC Capital Maintains Outperform on Doximity, Raises Price Target to $34
Doximity, Inc. Q2 2027 Earnings Call Summary
Evercore ISI Group Maintains In-Line on Doximity, Lowers Price Target to $33
Doximity (DOCS) Q2 2027 Earnings Call Transcript
Doximity, Inc. Announces Fiscal 2027 Second Quarter Financial Results
Needham Reiterates Buy on Doximity, Maintains $41 Price Target
Doximity Inc (DOCS) Q2 2027 Earnings Call Highlights: AI Search Becomes Eight-Figure Business ...
Doximity (NYSE:DOCS) Shares Fall on Soft Guidance and Margin Pressure
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.